GSA CAPITAL PARTNERS LLP 13D/13G Filings for Galera Therapeutics, Inc. (GRTX)

GSA CAPITAL PARTNERS LLP 13D and 13G filings for Galera Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-01-02
08:35 am
Purchase
2024-01-0213GGalera Therapeutics, Inc.
GRTX
GSA CAPITAL PARTNERS LLP3,892,561
7.156%
3,892,561increase
(New Position)
Filing